Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kala Pharmaceuticals
Biotech
Biotechs cut pipeline prospects to focus on priority programs
Preparing for a prolonged bear market, a raft of biotechs have decided candidates that looked good a few months ago are now an extravagance.
Nick Paul Taylor
Aug 11, 2022 9:43am
Metis poaches Kala CSO to support move into the clinic
Jan 20, 2022 8:30am
Celgene brings on Keytruda R&D executive—Chutes & Ladders
Oct 26, 2018 9:00am
Shire’s ophthalmic medical lead joins Kala Pharmaceuticals as VP
Oct 25, 2018 11:00am
Trevena CMO exit; AMO deal; Kala IPO; AliveCor-Mayo pact—News of Note
Jul 20, 2017 10:03am
Langer’s Kala files for $86M IPO to bring eye drug to market
Jun 26, 2017 6:42am
